Switch to:
Abbott Laboratories (NYSE:ABT)
Research and Development
$1,471 Mil (TTM As of Mar. 2016)

This is the expense the company spent on research and development. Abbott Laboratories's research and development for the three months ended in Mar. 2016 was $379 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2016 was $1,471 Mil.


Definition

This is the expense the company spent on research and development.

Abbott Laboratories Research & Development for the trailing twelve months (TTM) ended in Mar. 2016 was 345 (Jun. 2015 ) + 378 (Sep. 2015 ) + 369 (Dec. 2015 ) + 379 (Mar. 2016 ) = $1,471 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Abbott Laboratories Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Research & Development 2,2552,5062,6892,9143,7241,5121,4611,3711,3451,405

Abbott Laboratories Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Research & Development 369310305361313345378369379348
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK